Foghorn Therapeutics FHTX
NASDAQ FHTX
$2.09 +0.19 (+10.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Foghorn Therapeutics (FHTX) Short term Debt (2019 - 2020)

Updated

Foghorn Therapeutics (FHTX) recorded Short term Debt of $5.99 million in Q3 2020.

Analysis

Foghorn Therapeutics (FHTX) Short term Debt (2019 - 2020) Analysis & Trends

At the end of FY2019, Foghorn Therapeutics reported Short term Debt of $4.15 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Foghorn Therapeutics 113.93 Mn -202.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 5.99 Mn
Dec 31, 2019 4.15 Mn
API Access

Foghorn Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=FHTX&period=max&api_key=YOUR_API_KEY